help  | faq  | software  | BAR

Publication : A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.

First Author  Iughetti P Year  2001
Journal  Cancer Res Volume  61
Pages  7375-8 PubMed ID  11606364
Issue  20

1 Entities

Trail: Publication